论文部分内容阅读
目的:分析阿仑膦酸钠联合注射用骨肽治疗骨质疏松症的临床疗效。方法:选取2014年11月至2016年3月收治的骨质疏松症患者92例,随机分为两组各46例,对照组行阿仑膦酸钠联合钙尔奇D治疗,观察组行阿仑膦酸钠联合注射用骨肽治疗,比较两组疗效。结果:两组治疗期间不良反应发生率无显著差异(P>0.05),治疗后观察组疼痛程度评分明显低于对照组,前臂近端骨密度及远端骨密度显著高于对照组(P<0.05)。结论:阿仑膦酸钠联合注射用骨肽治疗骨质疏松症效果显著。
Objective: To analyze the clinical efficacy of alendronate combined with bone peptide for the treatment of osteoporosis. Methods: A total of 92 patients with osteoporosis admitted from November 2014 to March 2016 were randomly divided into two groups (n = 46). The control group was treated with alendronate combined with Calcium D, and the observation group Ramon sodium combined with bone peptide injection therapy, the two groups were compared. Results: There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). After treatment, the score of pain in the observation group was significantly lower than that of the control group. The proximal and distal BMD of the forearm were significantly higher than those of the control group (P < 0.05). Conclusion: The combination of alendronate and bone peptide for injection in the treatment of osteoporosis is effective.